MedTrace Logo

The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study

NCT00240279 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2010-11-19

No results posted yet for this study

Summary

To investigate the effect of rosuvastatin compared to placebo on the aortic stiffness in hemodialysis patients as measured by pulse wave velocity (at 3, 6 and 12 months)

Conditions

Interventions

DRUG

Rosuvastatin

PROCEDURE

aortic pulse wave velocity measurements

Sponsors & Collaborators

Principal Investigators

  • AstraZeneca Crestor Medical Sciences Director, MD · AstraZeneca

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00240279 on ClinicalTrials.gov